Versant Capital Management »

Igm Biosciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Igm Biosciences (IGMS) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Igm Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Igm Biosciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Igm Biosciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.8k 169 16.54

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Vaneck Gold Miners Etf Etf (GDX)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)
Dimensional Us Marketwide Value Etf Etf (DFUV)

View all positions for Versant Capital Management

Top funds holding Igm Biosciences

Baker Bros. Advisors
T. Rowe Price Associates
Siren
Redmile Group
Goldman Sachs Group
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Invesco
Northern Trust
TD Asset Management
Charles Schwab Investment Management
Morgan Stanley

View all funds holding Igm Biosciences